Your browser doesn't support javascript.
loading
TAD boundary deletion causes PITX2-related cardiac electrical and structural defects.
Baudic, Manon; Murata, Hiroshige; Bosada, Fernanda M; Melo, Uirá Souto; Aizawa, Takanori; Lindenbaum, Pierre; van der Maarel, Lieve E; Guedon, Amaury; Baron, Estelle; Fremy, Enora; Foucal, Adrien; Ishikawa, Taisuke; Ushinohama, Hiroya; Jurgens, Sean J; Choi, Seung Hoan; Kyndt, Florence; Le Scouarnec, Solena; Wakker, Vincent; Thollet, Aurélie; Rajalu, Annabelle; Takaki, Tadashi; Ohno, Seiko; Shimizu, Wataru; Horie, Minoru; Kimura, Takeshi; Ellinor, Patrick T; Petit, Florence; Dulac, Yves; Bru, Paul; Boland, Anne; Deleuze, Jean-François; Redon, Richard; Le Marec, Hervé; Le Tourneau, Thierry; Gourraud, Jean-Baptiste; Yoshida, Yoshinori; Makita, Naomasa; Vieyres, Claude; Makiyama, Takeru; Mundlos, Stephan; Christoffels, Vincent M; Probst, Vincent; Schott, Jean-Jacques; Barc, Julien.
  • Baudic M; Nantes Université, CHU Nantes, CNRS, INSERM, l'institut du Thorax, F-44000, Nantes, France.
  • Murata H; The Department of Cardiovascular Medicine, Nippon Medical School Hospital, Tokyo, Japan.
  • Bosada FM; Department of Medical Biology, Amsterdam Cardiovascular Sciences, Amsterdam University Medical Centers, University of Amsterdam, 1105 AZ, Amsterdam, The Netherlands.
  • Melo US; Max Planck Institute for Molecular Genetics, RG Development and Disease, 13353, Berlin, Germany.
  • Aizawa T; Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan.
  • Lindenbaum P; Nantes Université, CHU Nantes, CNRS, INSERM, l'institut du Thorax, F-44000, Nantes, France.
  • van der Maarel LE; Department of Medical Biology, Amsterdam Cardiovascular Sciences, Amsterdam Reproduction and Development, Amsterdam University Medical Centers, University of Amsterdam, 1105 AZ, Amsterdam, The Netherlands.
  • Guedon A; Nantes Université, CHU Nantes, CNRS, INSERM, l'institut du Thorax, F-44000, Nantes, France.
  • Baron E; Nantes Université, CHU Nantes, CNRS, INSERM, l'institut du Thorax, F-44000, Nantes, France.
  • Fremy E; Nantes Université, CHU Nantes, CNRS, INSERM, l'institut du Thorax, F-44000, Nantes, France.
  • Foucal A; Nantes Université, CHU Nantes, CNRS, INSERM, l'institut du Thorax, F-44000, Nantes, France.
  • Ishikawa T; Omics Research Center, National Cerebral and Cardiovascular Center, Suita, Japan.
  • Ushinohama H; Department of Cardiology, Fukuoka Children's Hospital, Fukuoka, Japan.
  • Jurgens SJ; Cardiovascular Disease Initiative, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Choi SH; Department of Experimental Cardiology, Heart Center, Amsterdam Cardiovascular Sciences, Amsterdam UMC Location University of Amsterdam, Amsterdam, The Netherlands.
  • Kyndt F; Cardiovascular Disease Initiative, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Le Scouarnec S; Department of Biostatistics, Boston University School of Public Health, Boston, MA, USA.
  • Wakker V; Nantes Université, CHU Nantes, CNRS, INSERM, l'institut du Thorax, F-44000, Nantes, France.
  • Thollet A; Nantes Université, CHU Nantes, CNRS, INSERM, l'institut du Thorax, F-44000, Nantes, France.
  • Rajalu A; Department of Medical Biology, Amsterdam Cardiovascular Sciences, Amsterdam University Medical Centers, University of Amsterdam, 1105 AZ, Amsterdam, The Netherlands.
  • Takaki T; Nantes Université, CHU Nantes, CNRS, INSERM, l'institut du Thorax, F-44000, Nantes, France.
  • Ohno S; Nantes Université, CHU Nantes, CNRS, INSERM, l'institut du Thorax, F-44000, Nantes, France.
  • Shimizu W; Department of Cell Growth and Differentiation, Center for iPS Cell Research and Application, Kyoto University, Kyoto, Japan.
  • Horie M; Takeda-CiRA Joint Program for iPS Cell Applications, Fujisawa, Japan.
  • Kimura T; Department of Pancreatic Islet Cell Transplantation, National Center for Global Health and Medicine, Tokyo, Japan.
  • Ellinor PT; Department of Bioscience and Genetics, National Cerebral and Cardiovascular Center Research Institute, Suita, Japan.
  • Petit F; The Department of Cardiovascular Medicine, Nippon Medical School Hospital, Tokyo, Japan.
  • Dulac Y; Department of Cardiovascular Medicine, Shiga University of Medical Science, Ohtsu, Japan.
  • Bru P; Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan.
  • Boland A; Cardiovascular Disease Initiative, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Deleuze JF; Cardiovascular Research Center, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Redon R; Demoulas Center for Cardiac Arrhythmias, Massachusetts General Hospital, Boston, MA, USA.
  • Le Marec H; Service de Génétique Clinique, CHU Lille, Hôpital Jeanne de Flandre, F-59000, Lille, France.
  • Le Tourneau T; University of Lille, EA 7364-RADEME, F-59000, Lille, France.
  • Gourraud JB; Unité de Cardiologie Pédiatrique, Hôpital des Enfants, F-31000, Toulouse, France.
  • Yoshida Y; Service de Cardiologie, GH La Rochelle, F-17019, La Rochelle, France.
  • Makita N; Université Paris-Saclay, CEA, Centre National de Recherche en Génomique Humaine (CNRGH), 91057, Evry, France.
  • Vieyres C; Université Paris-Saclay, CEA, Centre National de Recherche en Génomique Humaine (CNRGH), 91057, Evry, France.
  • Makiyama T; Nantes Université, CHU Nantes, CNRS, INSERM, l'institut du Thorax, F-44000, Nantes, France.
  • Mundlos S; Nantes Université, CHU Nantes, CNRS, INSERM, l'institut du Thorax, F-44000, Nantes, France.
  • Christoffels VM; Nantes Université, CHU Nantes, CNRS, INSERM, l'institut du Thorax, F-44000, Nantes, France.
  • Probst V; Nantes Université, CHU Nantes, CNRS, INSERM, l'institut du Thorax, F-44000, Nantes, France.
  • Schott JJ; European Reference Network for Rare and Low Prevalence Complex Diseases of the Heart: ERN GUARD-Heart, Amsterdam, The Netherlands.
  • Barc J; Department of Cell Growth and Differentiation, Center for iPS Cell Research and Application, Kyoto University, Kyoto, Japan.
Nat Commun ; 15(1): 3380, 2024 Apr 20.
Article en En | MEDLINE | ID: mdl-38643172
ABSTRACT
While 3D chromatin organization in topologically associating domains (TADs) and loops mediating regulatory element-promoter interactions is crucial for tissue-specific gene regulation, the extent of their involvement in human Mendelian disease is largely unknown. Here, we identify 7 families presenting a new cardiac entity associated with a heterozygous deletion of 2 CTCF binding sites on 4q25, inducing TAD fusion and chromatin conformation remodeling. The CTCF binding sites are located in a gene desert at 1 Mb from the Paired-like homeodomain transcription factor 2 gene (PITX2). By introducing the ortholog of the human deletion in the mouse genome, we recapitulate the patient phenotype and characterize an opposite dysregulation of PITX2 expression in the sinoatrial node (ectopic activation) and ventricle (reduction), respectively. Chromatin conformation assay performed in human induced pluripotent stem cell-derived cardiomyocytes harboring the minimal deletion identified in family#1 reveals a conformation remodeling and fusion of TADs. We conclude that TAD remodeling mediated by deletion of CTCF binding sites causes a new autosomal dominant Mendelian cardiac disorder.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Células Madre Pluripotentes Inducidas Límite: Animals / Humans Idioma: En Año: 2024 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Células Madre Pluripotentes Inducidas Límite: Animals / Humans Idioma: En Año: 2024 Tipo del documento: Article